7 research outputs found

    Results of quality assessments according to ELCWP criteria.

    No full text
    <p>Score distributions are expressed by the mean values. IHC, immunohistochemistry; ELISA, enzyme linked immunosorbent assay; NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer; Significant, significant prognostic factor for survival (P<0.05); Non-significant, not significant prognostic factor for survival (P>0.05).</p

    Main characteristics of 22 eligible studies in the meta-analysis.

    No full text
    <p>IHC, immunohistochemistry; ELISA, enzyme linked immunosorbent assay; AC, adenocarcinoma; SCC, squamous cell carcinoma; Non-SCC, not squamous cell carcinoma; HR, hazard ration; ED, extensive-stage disease; LD, limited-disease stage; NA, not applicable; NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer.</p

    Forest plots of OS assessing bFGF expression in retrospective studies and prospective studies.

    No full text
    <p>Forest plots of OS assessing bFGF expression in retrospective studies and prospective studies.</p

    Forest plots of OS assessing bFGF expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).

    No full text
    <p>Forest plots of OS assessing bFGF expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).</p

    Sensitivity analysis for combined HRs evaluating bFGF expression on OS.

    No full text
    <p>Sensitivity analysis for combined HRs evaluating bFGF expression on OS.</p

    Forest plots of OS associated with bFGF expression in lung cancer.

    No full text
    <p>Forest plots of OS associated with bFGF expression in lung cancer.</p
    corecore